Literature DB >> 22806988

Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transport.

Masahiro Shinohara1, Masaki Nakamura, Hironari Masuda, Jun Hirose, Yuho Kadono, Mitsuyasu Iwasawa, Yuuichi Nagase, Kohjiro Ueki, Takashi Kadowaki, Takehiko Sasaki, Shigeaki Kato, Hiroaki Nakamura, Sakae Tanaka, Hiroshi Takayanagi.   

Abstract

Class IA phosphatidylinositol 3-kinases (PI3Ks) are activated by growth factor receptors and regulate a wide range of cellular processes. In osteoclasts, they are activated downstream of α(v) β(3) integrin and colony-stimulating factor-1 receptor (c-Fms), which are involved in the regulation of bone-resorbing activity. The physiological relevance of the in vitro studies using PI3K inhibitors has been of limited value, because they inhibit all classes of PI3K. Here, we show that the osteoclast-specific deletion of the p85 genes encoding the regulatory subunit of the class IA PI3K results in an osteopetrotic phenotype caused by a defect in the bone-resorbing activity of osteoclasts. Class IA PI3K is required for the ruffled border formation and vesicular transport, but not for the formation of the sealing zone. p85α/β doubly deficient osteoclasts had a defect in macrophage colony-stimulating factor (M-CSF)-induced protein kinase B (Akt) activation and the introduction of constitutively active Akt recovered the bone-resorbing activity. Thus, the class IA PI3K-Akt pathway regulates the cellular machinery crucial for osteoclastic bone resorption, and may provide a molecular basis for therapeutic strategies against bone diseases.
Copyright © 2013 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22806988     DOI: 10.1002/jbmr.1703

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  19 in total

Review 1.  Signaling inputs to invadopodia and podosomes.

Authors:  Daisuke Hoshino; Kevin M Branch; Alissa M Weaver
Journal:  J Cell Sci       Date:  2013-07-10       Impact factor: 5.285

2.  Editorial: lipid kinases and bone homeostasis: lessons learned from phosphoinositide 3-kinase isoform-specific knockouts.

Authors:  Junjie Xing; Mary Beth Humphrey
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

Review 3.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

4.  Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.

Authors:  Chunyan Jiang; Yan Wang; Mengqi Zhang; Jin Xu
Journal:  Mol Biol Rep       Date:  2022-07-26       Impact factor: 2.742

5.  Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.

Authors:  Naga Suresh Adapala; Danielle Holland; Vanessa Scanlon; Mary F Barbe; Wallace Y Langdon; Alexander Y Tsygankov; Joseph A Lorenzo; Archana Sanjay
Journal:  Bone       Date:  2014-07-01       Impact factor: 4.398

Review 6.  Osteopetrosis: genetics, treatment and new insights into osteoclast function.

Authors:  Cristina Sobacchi; Ansgar Schulz; Fraser P Coxon; Anna Villa; Miep H Helfrich
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

7.  Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.

Authors:  Naga Suresh Adapala; Mary F Barbe; Alexander Y Tsygankov; Joseph A Lorenzo; Archana Sanjay
Journal:  J Cell Biochem       Date:  2014-07       Impact factor: 4.429

8.  Integrative Analysis of Transcriptomic and Epigenomic Data to Reveal Regulation Patterns for BMD Variation.

Authors:  Ji-Gang Zhang; Li-Jun Tan; Chao Xu; Hao He; Qing Tian; Yu Zhou; Chuan Qiu; Xiang-Ding Chen; Hong-Wen Deng
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

Review 9.  Mouse Cre Models for the Study of Bone Diseases.

Authors:  Sarah L Dallas; Yixia Xie; Lora A Shiflett; Yasuyoshi Ueki
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

10.  Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α.

Authors:  Ling Wang; Xue-Min Qiu; Yu-Yan Gui; Ying-Ping Xu; Hans-Jürgen Gober; Da-Jin Li
Journal:  Drug Des Devel Ther       Date:  2015-07-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.